| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/25/2005 | US20050186667 nucleotide sequence encoding PNCK that is temporally expressed during postnatal mammary development in a spatially heterogeneous manner in certain subsets of cells, and overexpressed in a subset of primary breast cancers; used as prognostic tools, screening tools and in therapies |
| 08/25/2005 | US20050186664 Albumin fusion proteins |
| 08/25/2005 | US20050186663 Cystine-knot fold protein |
| 08/25/2005 | US20050186662 Follicle stimulating hormone-immunoglobulin fusion fo use in treatment of reproductive disorders |
| 08/25/2005 | US20050186661 Via peptone iv derived from soybean, supplemented with corn steep liquor, beef extract, tryptone, casein, and gelatin; bacteriocin-release-proteins; tolerant to leucine, cysteine, arginine, glycine, asparagine (BDH) and aspartic acid; heat treatment; freeze drying; for use in detergents |
| 08/25/2005 | US20050186659 Methods for protein purification |
| 08/25/2005 | US20050186658 Chimeric metabotropic glutamate receptors and uses thereof |
| 08/25/2005 | US20050186631 Nematode PPPT-like sequences |
| 08/25/2005 | US20050186628 Dorsalin-1 polypeptide and uses thereof |
| 08/25/2005 | US20050186610 Tumor protein fusion for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/25/2005 | US20050186608 Therapeutic polypeptide recovered from mammalian milk for diagnosis, prevention and treatment of insulin resistance, cardiovascular and hypotensive disorders |
| 08/25/2005 | US20050186601 Nucleic acid detection |
| 08/25/2005 | US20050186600 Polynucleotides encoding novel UbcH10 polypeptides and kits and methods using same |
| 08/25/2005 | US20050186599 Human protein for use in identifying modulator for diagnosis, drug screening, clinical trial monitoring and treatment of metabolic disorders; cosmetics; nutriceutical |
| 08/25/2005 | US20050186592 Forming polymers having diverse monomer sequences on a single substrate; synthesizing high-density arrays of diverse polymer sequences such as oligonucleotides and/or peptides |
| 08/25/2005 | US20050186591 Method of treating neurodegenerative disease |
| 08/25/2005 | US20050186584 Mutant serine/threonine kinase for use as diagnostic indicator of cell proliferative disorders; antiproliferative agents; enzyme inhibitors |
| 08/25/2005 | US20050186574 Anterior gradient 2 homolog (AGR2) for use as to in identifying modulator for treatment of asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis, vision defects, inflammatory bowel and cell proliferative disorders |
| 08/25/2005 | US20050186573 Polynucleotides for use as tags and tag complements in the detection of nucleic acid sequences |
| 08/25/2005 | US20050186569 Nucleic acid-associated proteins |
| 08/25/2005 | US20050186568 Enzymatic polypeptides for use as drug screening tools; pharmacological toxicity |
| 08/25/2005 | US20050186217 Compositions produced using enteric pathogens and methods of use |
| 08/25/2005 | US20050186215 CUDR as biomarker for cancer progression and therapeutic response |
| 08/25/2005 | DE102004006477A1 Process for demonstrating the presence of single nucleotide polymorphism in human genes, comprises using a priming agent |
| 08/25/2005 | CA2556088A1 Compositions and methods for modifying the content of polyunsaturated fatty acids in biological cells |
| 08/25/2005 | CA2555877A1 Hybrid polypeptides with selectable properties |
| 08/25/2005 | CA2555675A1 Nicotinamide riboside kinase compositions and methods for using the same |
| 08/25/2005 | CA2555657A1 Tb resistance assay |
| 08/25/2005 | CA2555597A1 Radiolabeled compounds and compositions, their precursors and methods for their production |
| 08/25/2005 | CA2555531A1 Methods and compositions for combination rnai therapeutics |
| 08/25/2005 | CA2555335A1 Rnai therapeutics for treatment of eye neovascularization diseases |
| 08/25/2005 | CA2554212A1 Rna interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional sina) |
| 08/25/2005 | CA2550429A1 Method of prognosis of metastasis by detection of fra12e fragile site within the smrt gene/locus at chromosome 12q24 |
| 08/24/2005 | EP1566437A1 Adsorption of nucleic acids to a solid phase |
| 08/24/2005 | EP1565714A2 Uncaging devices |
| 08/24/2005 | EP1565583A2 Hiv vaccine formulations |
| 08/24/2005 | EP1565582A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565579A2 Methods for identifying risk of breast cancer and treatments thereof |
| 08/24/2005 | EP1565578A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 08/24/2005 | EP1565487A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 08/24/2005 | EP1565482A2 A34 and a33-like 3 dna, proteins, antibodies thereto and methods of treatment using same |
| 08/24/2005 | EP1565480A2 Detectable labeled nucleoside analogs and methods of use thereof |
| 08/24/2005 | EP1565479A2 2'-o-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
| 08/24/2005 | EP1565205A2 Interferon-alpha polypeptides and conjugates |
| 08/24/2005 | EP1565080A2 Novel immunogenic proteins of leptospira |
| 08/24/2005 | EP1444344A4 Novel 88 phage vectors |
| 08/24/2005 | CN1659438A G-protein coupled receptor ligands and methods |
| 08/24/2005 | CN1659282A Bacillus licheniformis mutant host cell |
| 08/24/2005 | CN1659274A Cytokine receptor |
| 08/24/2005 | CN1659179A System for tracing animal products |
| 08/24/2005 | CN1658906A Mycoplasma polypeptides |
| 08/24/2005 | CN1657537A Central body located gene and its use in medicinal region |
| 08/24/2005 | CN1216153C Method for specificity molecule marker of penicillum IPC strain and its application |
| 08/24/2005 | CN1216076C Monoclonal antibody resisting human small cell lung carcinoma and its application |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933132 Regulation of immune responses by attractin |
| 08/23/2005 | US6933117 Composition for use in the automated medical and genetic analysis |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 08/18/2005 | WO2005075655A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 08/18/2005 | WO2005075639A1 Method of constructing glycoprotein by using extension codon |
| 08/18/2005 | WO2005075496A1 A method for the simultaneous determination of blood group and platelet antigen genotypes |
| 08/18/2005 | WO2005074650A2 Modified human four helical bundle polypeptides and their uses |
| 08/18/2005 | WO2005074647A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 08/18/2005 | WO2005074546A2 Modified human growth hormone polypeptides and their uses |
| 08/18/2005 | WO2005074524A2 Modified human interferon polypeptides and their uses |
| 08/18/2005 | WO2005074436A2 Self-assembling split-fluorescent protein systems |
| 08/18/2005 | WO2005058952A3 Ztnf13, a tumor necrosis factor |
| 08/18/2005 | WO2005058369A3 Compositions of l-caldesmon for treating viral infection |
| 08/18/2005 | WO2005054810A3 Polymorphic cd24 genotypes that are predictive of multiple sclerosis risk and progression |
| 08/18/2005 | WO2005054435A3 Methods and compositions for in vitro amplification of extrachromosomal nucleic acid |
| 08/18/2005 | WO2005054236B1 Substituted quinolines for the treatment of cancer |
| 08/18/2005 | WO2005052123A3 Polynucleotide encoding a novel human g-protein coupled receptor variant of the relaxin receptor, hgprbmy5v1, and variants thereof |
| 08/18/2005 | WO2005047487A8 Motoneuronotrophic factor gene sequences |
| 08/18/2005 | WO2005045056A3 Radioactive multiplexing analytical methods |
| 08/18/2005 | WO2005045041A3 Rna interference mediated inhibition of cholesteryl ester transfer protein (cetp) gene expression using short interfering nucleic acid (sina) |
| 08/18/2005 | WO2005045000A3 Estrogen receptor gene variation and disease |
| 08/18/2005 | WO2005038427A3 Rapid identification of viruses of the upper respiratory tract infection including sars causing coronus viruses |
| 08/18/2005 | WO2005033133A3 Polynucleotides encoding erbb-2 polypeptides and kits and methods using same |
| 08/18/2005 | WO2005023865A3 Antibody-producing cell lines expressing activation-induced-cytidine-deaminase and a dominant negative allele of a mismatch repair gene |
| 08/18/2005 | WO2005020794A8 Taxane chemosensitivity prediction test |
| 08/18/2005 | WO2005019419B1 Co-detection of single polypeptide and polynucleotide molecules |
| 08/18/2005 | WO2005018436A3 Methods for the diagnosis, prognosis and treatment of metabolic syndrome |
| 08/18/2005 | WO2005017125A3 Method for isolation and replication of infectious human hepatitis-c virus |
| 08/18/2005 | WO2005016233A3 Botulinum neurotoxin b receptors and use thereof |
| 08/18/2005 | WO2005007663A3 Fluorogenic enzyme substrates and uses thereof |
| 08/18/2005 | WO2005003291A3 Bead bound combinatorial oligonucleoside phosphorothioate and phosphorodithioate aptamer libraries |
| 08/18/2005 | WO2004094597A3 Anthozoan fluorescent protein genes |
| 08/18/2005 | WO2004084821A3 Hemipteran glutamate decarboxylase |
| 08/18/2005 | WO2004072246A3 Polymerase-based protocols for the introduction of combinatorial deletions and insertions |
| 08/18/2005 | WO2004028458A3 Antisense modulation of microsomal prostaglandin e2 synthase expression |
| 08/18/2005 | US20050183159 Floral organ tissue-specific expression of isopentenyl transferase |
| 08/18/2005 | US20050182251 Process for the synthesis of oligomeric compounds |
| 08/18/2005 | US20050182250 Nucleotide sequences coding fluorescent reporter protlein and scaffolds for use as diagnostic and imaging tool in genetic analysis |
| 08/18/2005 | US20050182249 Nucleotide sequences coding tumor suppressor protein for use in diagnosis, prevention and treatment of cancer; antitumor agents |
| 08/18/2005 | US20050182241 Polysubstituted catechol-based universal solid supports; Dimethoxycatechol |
| 08/18/2005 | US20050182017 Immunostimulatory nucleic acid molecules |
| 08/18/2005 | US20050182012 NF-kappaB oligonucleotide decoy molecules |
| 08/18/2005 | US20050182009 siNA molecule comprising a double-stranded structure that down-regulates expression of NF-Kappa B / REL-A , wherein said siNA molecule does not require the presence of nucleotides having a 2'-hydroxy group within the siNA molecule for mediating RNA interference |
| 08/18/2005 | US20050182008 chemically synthesized double stranded siNA; NOGO genes encode potent inhibitors of neurite outgrowth; treating various nervous system disorders such as brain or spinal cord injury, cerebrovascular disorders, Alzheimer's disease, dementia, and neurodegenerative disorders |